You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

COVID-19 Resource Center

Healthcare professionals can find help and guidance on how to benefit from our offerings to treat your patients, as well as other practical information and advice.

Read more

News

Prospectus for the rights issue in Getinge AB available

Not for release, publication or distribution, directly or indirectly, in the United States, Canada, Australia, Hong Kong or Japan

Prospectus for the rights issue in Getinge AB available

The prospectus prepared by the board of directors of Getinge AB (“Getinge”) with respect to the share issue with preferential rights for the shareholders of Getinge is now available on the company’s website www.getingegroup.com, on the website of SEB Enskilda, www.seb.se/prospekt. The prospectus will also be available at the company’s head office in Getinge from Tuesday December 2, 2008. The prospectus will be sent by mail to all directly registered shareholders.

The prospectus is also available free of charge from Getinge AB, PO Box 69, SE-310 44 Getinge, Sweden, telephone number +46 35 15 55 00 as well as from SEB Enskilda, Skandinaviska Enskilda Banken AB, Kungsträdgårdsgatan 8, SE-106 40 Stockholm, Sweden, telephone number +46 (0)8 52 22 95 71.

Getinge November 27, 2008
Getinge AB (publ)
www.getingegroup.com

For more information:
Ulf Grunander, CFO
+46 (0) 35 15 55 00


This information is such that Getinge AB must disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. This information was submitted for publication on November 27, 2008 at 14.30.

Files

Share: